NCT01345461

Brief Summary

As the critical care practice has improved over the last decades more patients are recovering from intensive care therapy. However, muscle atrophy and neuromuscular dysfunction are commonly observed sequelae after critical illness and are thought to play important roles in the development of intensive care unit acquired weakness (ICUAW). As a consequence, these entities may contribute to the impaired physical function and prolonged convalescence reported by ICU patients up to twelve months after discharge. Thus, strategies to counteract muscle atrophy and neuromuscular dysfunction acquired during the ICU stay may therefore potentially improve physical outcome and reduce the overall burden of critical illness. Limited information is available on muscle function in ICU patients and to our knowledge no muscle stimulation methods are currently available for evaluating muscle fatigue in large, proximal muscles groups, such as m. quadriceps, in non-cooperating ICU patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 15, 2011

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 2, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

September 29, 2017

Status Verified

September 1, 2017

Enrollment Period

1.3 years

First QC Date

April 15, 2011

Last Update Submit

September 27, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fatigue Index (ratio)

    The tetanic stimulation period was subdivided into five intervals. For each interval the resistance to muscle fatigue was expressed as a Fatigue Index (FI) and calculated as the ratio between the sum of peak torque values from the final three contractions relative to the sum of peak torque values from the first three contractions.

    One week

Secondary Outcomes (1)

  • Slope of regression line (Nm/s)

    One week

Study Arms (1)

Healthy adult volunteers

Twelve healthy adult volunteers (6 men, 6 women)

Device: transcutaneous electrical muscle stimulation, (model DS7A, Digitimer, Welwyn, Garden City, Hertfordshire, UK)

Interventions

two constant current high voltage stimulators delivered ten single stimuli twitches with biphasic square pulses at widths of 300 μs. A train generator was then switched on, triggering the delivery a 35 Hz current in bouts of 3 seconds periods separated by 1-second pause for a total of 40 tetanic contractions. In immediate succession to the tetanic contractions a second series of ten single twitch stimuli ended the protocol.

Also known as: Health young subjects
Healthy adult volunteers

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

healthy adult volunteers

You may qualify if:

  • healthy adult volunteers

You may not qualify if:

  • medical history of cardiovascular, metabolic or neuromuscular disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of intensive care 4131, Rigshospitalet, Copenhagen University Hospital

Copenhagen, DK-2100 OE, Denmark

Location

Related Publications (1)

  • Poulsen JB, Rose MH, Moller K, Perner A, Jensen BR. A Novel Noninvasive Method for Measuring Fatigability of the Quadriceps Muscle in Noncooperating Healthy Subjects. Biomed Res Int. 2015;2015:193493. doi: 10.1155/2015/193493. Epub 2015 Jul 21.

MeSH Terms

Conditions

Fatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jesper B Poulsen, MD

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

April 15, 2011

First Posted

May 2, 2011

Study Start

January 1, 2010

Primary Completion

May 1, 2011

Study Completion

June 1, 2011

Last Updated

September 29, 2017

Record last verified: 2017-09

Locations